Fred Doloresco PharmD, MS

Fred Doloresco

Fred Doloresco
PharmD, MS

Director of Assessment; Clinical Associate Professor; Research Assistant Professor

Department of Pharmacy Practice

School of Pharmacy

Contact Information
216 Kapoor Hall
Buffalo, NY 14214-8033
Phone: (716) 645-3932
frediii@buffalo.edu



Professional Summary:

Research interests in pharmacoeconomics, outcomes research, and health services research. Specific areas of research include cost-effectiveness clinical pharmacy services.

Education and Training:

  • MS, University of Wisconsin (2008)
  • PharmD, Purdue University (2005)
  • BS, Miami University (2000)

Employment:

  • Clinical Instructor (2005–2008)
  • Clinical Instructor (2005)
  • Researcher (2003)
  • Researcher (2003)
  • Researcher (1998–2000)
  • Researcher (1998)

Awards and Honors:

  • Commendation (2012)
  • Most Downloaded Article (2010)


Journal Articles:

  • Hoffman JM; Li E; Doloresco F; Matusiak L; Hunkler RJ; Shah ND; Vermeulen LC; Schumock GT. Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013. American Journal of Health-System Pharmacy. 2013; 70.
  • Hoffman JM; Li E; Doloresco F; Matusiak L; Hunkler RJ; Shah ND; Vermeulen LC; Schumock GT. Projecting future drug expenditures--2012.. American Journal of Health-System Pharmacy. 2012; 69.
  • Doloresco F; Fominaya C; Schumock GT; Vermeulen LC; Matusiak L; Hunkler RJ; Shah ND; Schumock GT. Projecting future drug expenditures--2011.. American Journal of Health-System Pharmacy. 2011; 67.
  • Wilson S; Wahler RG; Brown J; Doloresco F; Monte SV. Impact of Pharmacist Intervention on Clinical Outcomes in the Palliative Care Setting. American Journal of Hospice and Palliative Medicine. 2010; 28.
  • Doloresco F; Fominaya C; Schumock G; Vermeulen LC; Matusiak L; Hunkler RJ; Nilay S; Hoffman J. Projecting future drug expenditures--2010.. American Journal of Health-System Pharmacy. 2010; 68.
  • Brown J; Doloresco F; Forrest A. Outcomes and Costs Associated with Prior Vancomycin Exposure in Patients with MRSA Complicated Bacteremia and Infective Endocarditis. Clinical Infectious Diseases. 2010.
  • Prescott WA; Doloresco F; Brown J; Paladino JA. Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review.. PharmacoEconomics. 2010; 28.
  • Doloresco F; Vermeulen LC. Global survey of hospital pharmacy practice.. American Journal of Health System Pharmacy. 2009; 66.
  • Hoffman JM; Shah ND; Vermeulen LC; Doloresco F; Martin PK; Blake S; Matusiak L; Hunkler RJ; Schumock GT. Projecting future drug expenditures--2009.. American Journal of Health-System Pharmacy. 2009; 66.
  • Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT; ACCP. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.. Pharmacotherapy. 2009; 29.
  • Hoffman JM; Shah ND; Vermeulen LC; Doloresco F; Grim P; Hunkler RJ; Hontz KM; Schumock GT. Projecting future drug expenditures--2009.. American Journal of Health-System Pharmacy. 2008; 65.
See all (1 more)

Abstracts:

  • Doloresco F; Brown J. Contrast-associated nephropathy following myocardial infarction among adults in U.S. community hospitals. American Society of Hospital Pharmacy. Midyear Meeting, December, 2010, Anaheim, CA. 2011.
  • Brown J; Doloresco F. Equality/inequality of inpatient outcomes for major infectious diseases in the United States. American College of Clinical Pharmacy Meeting, October, 2010, Austin, TX. 2011.
  • Brown J; Doloresco F. Respiratory outcomes associated with inhibition of the renin-angiotensin-aldosterone system among subjects with chronic obstructive pulmonary disease.. American College of Clinical Pharmacy Meeting, October, 2010, Austin, TX. 2011.
  • Brown J; Forrest A; Doloresco F. Outcomes and Costs of Previous Vancomycin Exposure in Patients with Complicated Bacteremia and Infective Endocarditis Due to MRSA. European Congress on Clinical Microbiology and Infectious Diseases. 2010.
  • Brown J; Doloresco F. Prior Vancomycin Exposure and its Impact on MRSA Pneumonia Related Outcomes and Costs. American College of Clinical Pharmacy Annual Meeting. 2009.
  • Brown J; Doloresco F. Prior Vancomycin Exposure and its Impact on MRSA Pneumonia Related Mortality. International Conference on Antimicrobial and Chemotherpy. 2009.

Professional Memberships:

  • American Association of Colleges of Pharmacy (2008)
  • International Pharmaceutical Federation (2008)
  • American College of Clinical Pharmacy; Secretary/Treasurer, Chair-elect, Chair - Health Outcomes PRN, Committee Assignment - Review of Economic Evaluations of Clinical Pharmacy Services - 2011-2013 (2006)
  • Phi Lambda Sigma (2004)
  • American Society of Healthsystem Pharmacists (2004)
  • Phi Delta Chi; Faculty Adviser (2001)

Presentations:

  • "Agreement of Online Drug Information Resources" 2013 Global Congress, International Pharmaceutical Federation (2013)
  • "Using Mediciad electronic data to compare effectiveness of chronic disease management" Electronic Data Methods Forum, Academy of Health (2013)
  • "Program Update: Prescriber Education Program" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2013)
  • "Diabetes Standards of Care" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2012)
  • "Metformin as First-Line Therapy for Type 2 Diabetes" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2012)
  • "Introducing Center for Health Outcomes Pharmacoinformatics and Epidemiology" Annual Meeting of Dean's National Industrial Advisory Council, UB School of Pharmacy and Pharmaceutical Sciences (2011)
  • "Influence of Part-Time Work on Academic Outcomes of Doctor of Pharmacy Students in the Era of Introductory Pharmacy Practice Experience (IPPE)." 2011 AACP Meeting, AACP (2011)
  • "Anabolic Steroids" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2011)
  • "Central Nervous System Stimulants" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2011)
  • "Non-benzodiazepine sedative-hypnotics" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2011)
  • "Cost-Effectiveness of Clinical Pharmacy Services" , NYCHS (2010)
  • "Propoxyphene" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Proton Pump Inhibitors" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Cost-Effectiveness of Clinical Pharmacy Services" , NYC Pharmacists Society (2010)
  • "Trends in Drug Expenditures - 2010 Update" , Pharmacy OneSource (2010)
  • "Clinical and Economic Justification of Clinical Pharmacy Services" Annual Preceptor Orientation, University at Buffalo School of Pharmacy (2010)
  • "Ophthalmic cyclosporine" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Oxycodone CR (OxyContin)" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Quinine sulfate (Qualaquin)" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Sublingual buprenorphine-containing products" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Quality-of-Life Instruments for Research: Considerations for Selection and Data Analysis" Spring Forum, American College of Clinical Pharmacy (2010)
  • "Becaplermin gel (Regranex)" NYS Medicaid Pharmacy & Therapeutics Committee, NYS Department of Health (2010)
  • "Non-fluoroquinolone ophthalmic antibiotics" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Ophthalmic antibiotic/steroid combination products" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Topical Antifungals" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Topical Corticosteroids" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Triptans" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2010)
  • "Becaplermin gel (Regranex)" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Ophthalmic fluoroquinolones" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Tramadol" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Human Growth Hormone" NYS Medicaid Pharmacy & Therapeutics Committee, NYS Department of Health (2009)
  • "Sodium Oxybate (Xyrem)" NYS Medicaid Pharmacy & Therapeutics Committee, NYS Department of Health (2009)
  • "Human Growth Hormone" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Ophthalmic cyclosporine" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Sodium Oxybate (Xyrem)" NYS Medicaid Drug Utilization Review Board, NYS Department of Health (2009)
  • "Acute Coronary Syndromes: Focus on Preventing Recurrent Cardiac Events" UB Continuing Education Program, UB SoPPS (2009)
  • "What's new in anti-platelet therapy" UB Continuing Education Program, UB SoPPS (2009)
  • "Complete findings of the BPP Special Project: A Global Survey of Hospital Pharmacy Practice" 68th International Congress, International Pharmaceutical Federation (2008)
See all (28 more)

Service Activities:

  • Committee for University-Wide Course Evaluations; Evaluation and selection of university-wide course evaluation tool.; Member (2013)
  • American College of Clinical Pharmacy; Liaison between ACCP and UB students.; Other (2012)
  • Search Committee - Associate Dean; Participated in selection of new Associate Dean of Assessment Offered position to qualified candidate, who started March 1, 2012.; Member (2012)
  • Health Outcomes PRN; American College of Clinical Pharmacy Responsible for ACCP Health Outcomes Practice and Research Network budgeting and communications.; Other (2011)
  • Search Committee - Data analyst (DoH); Member (2011)
  • Curriculum Committee; Attend curriculum committee meetings as a non-voting participant/guest. Identify how committee actions will affect Outcomes and Assessment Committee.; Other (2011)
  • Advisement committee; Attend meetings as a non-voting member/guest. Identify how actions of the committee affect Outcomes and Assessment Committee.; Other (2011)
  • Review of Economic Evaluations of Clinical Pharmacy Services; American College of Clinical Pharmacy Evaluation of cost-effectiveness of clinical pharmacy service. Ad-hoc committee assignment resulting in manuscript publication.; Member (2011)
  • Student Clinical Skills Competition Item Authors; American College of Clinical Pharmacy Authored questions related to health outcomes for student clinical skills competition. Items were peer-reviewed. Authored 15 items (100% of health outcomes questions) which were used at all levels of the competition.; Member (2011)
  • Outcomes and Assessment Committee; Chair of committee which creates plans and tools to measure and evaluate the PharmD program. Committee founded this year. Assisting with accreditation report.; Other (2011)
  • Health Outcomes PRN; American College of Clinical Pharmacy Responsible for ACCP Health Outcomes Practice and Research Network budgeting and communications.; Other (2010)
  • Mission Planning and Evaluation - (Accreditation Self-evaluation sub-committee); Member (2010)
  • Search Committee - Data analyst (DoH); Member (2010)
  • Search Committee - Outcomes Research Faculty; Coordinate interview of candidates for faculty position.; Other (2010)
  • Search Committee - Rapid Response Faculty; Member (2010)
  • Search Committee - RetroDUR staff; Member (2010)
  • Center for Health Outcomes, Pharmacoinformatics, and Epidemiology; Health Outcomes Lead; Other (2009)
  • Drug Utilization Review Committee; Oversight of review of pharmaceutical utilization for 5 million members of NYS Medicaid. Public presentation of summary reports to NYS Medicaid DUR board and P&T Committee. Billing and reimbursement for work performed. Liaison with multiple SUNY campuses; Other (2009)
  • Health Outcomes PRN Secretary/Treasurer; American College of Clinical Pharmacy Responsible for ACCP Health Outcomes Practice and Research Network budgeting and communications.; Other (2009)
  • Fellowship Program Steering Committee; Group oversight of UB fellowship recruiting and management.; Member (2009)
  • Pharmaceutical Care Committee; Evaluation and implementation of improvement of the pharmaceutical care sequence. Development and implementation of new content for move to Kapoor Hall. Integration of model pharmacy into curriculum. Integration of patient assessment lab into curriculum.; Member (2009)
  • Admissions committee; Assist in quality improvement of the School's admissions process.; Member (2009)
  • Fellowship Program Steering Committee; Committee responsible for oversight of fellowship programs.; Member (2009)
  • New York State Department of Health Outcomes Research Fellowship; Management of recruiting, advisement, and human resources for program.; Other (2009)
  • Accepted Students Day; Provide tours of UBSOPPS areas for pre-freshmen students. Have participated each year, providing tours of pharm care lab or model pharmacy.; Volunteer (2009)
  • Clinical Research Track Committee; Member (2009)
  • Medicaid Prescriber Education Program; Data analysis, budgeting, and customer service. Liaison with other SUNY campuses and NYS DOH.; Member (2009)
  • Retrospective Drug Utilization Review (RDUR) Program; Data analysis, training, and conduct of RDUR program. Interim chair 2012.; Member (2009)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

216 Kapoor Hall
Buffalo, NY 14214-8033
Phone: (716) 645-3932
frediii@buffalo.edu